Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflawell (boswellic acids) for cognitive impairment after traumatic brain injury
IRCT20170315033086N6Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of boswellic acid in traumatic brain injury (TBI) and confusion, sponsored by Tehran University of Medical Sciences. Started Jan 2019; status: completed.
02
Drugs
boswellic acid
03
Conditions
traumatic brain injury (TBI)confusion
Beyond the preview
Go deeper on IRCT20170315033086N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170315033086N6.